en ENGLISH
eISSN: 2300 - 8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Kontakt Zasady publikacji prac Standardy etyczne i procedury
SCImago Journal & Country Rank

 
3/2021
vol. 96
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Artykuł oryginalny

COVID-19 associated mucormycosis in head and neck region of children during current pandemic: Our experiences

Santosh K. Swain
1
,
Pragnya P. Jena
2
,
Smarita Lenka
1

1.
Department of Otorhinolaryngology, IMS and SUM hospital, Siksha “O” Anusandhan University, Odisha, India
2.
Department of Microbiology, IMS and SUM hospital, Siksha “O” Anusandhan University, Odisha, India
Pediatr Pol 2021; 96 (3): 162–167
Data publikacji online: 2021/09/29
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Metryki PlumX:


Introduction
Mucormycosis is a rare but severe fungal infection, particularly found in immunocompromised patients. Currently this dreaded mucormycosis is rising among COVID-19 paediatric patients during their treatment period or after their discharge from hospital. It is also called as black fungus. The aim of this study is to evaluate the COVID-19 associated mucormycosis (CAM) in head and neck region of the paediatric patients with its clinical manifestations and management.

Material and methods
This is a descriptive and prospective study of paediatric patients with COVID-19 associated mucormycosis (CAM) carried out at a postgraduate teaching hospital. This study was conducted between March 2020 to April 2021. Patient profile such as age, sex, comorbidities, clinical presentations, diagnosis and treatment of the CAM were analysed. There were 12 paediatric patients of CAM were enrolled in this study.

Results
Out of 12 paediatric patients of CAM, there were eight male and four female patients, aged from 3 years to 16 years. Out of the 12 patients, 3 were diabetic (25%). Three patients (25%) were taking prolonged systemic steroids with prolonged hospital ICU stay. Two children (16.66%) were under chemotherapy for acute leukaemia. The common clinical symptoms were facial swelling, facial pain, nasal block and nasal discharge. Diagnosis was confirmed by histological examination. All were treated with endoscopic surgical debridement and amphotericin B. Two patients were passed away; one was due to cerebral involvement and another was due to respiratory failure by pneumonia.

Conclusions
Early identification and prompt treatment in paediatric patients with CAM are required. Aggressive endoscopic surgical debridement for local control and appropriate systemic antifungal treatment will help to improve the prognosis and survival of the patients.